Nicholas E. Papadopoulos
Impact in
- Oncology top 2%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Vascular Tumors and Angiosarcomas
-
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 41
- Cutaneous Melanoma Detection and Management 20
- CAR-T cell therapy research 10
- HER2/EGFR in Cancer Research 7
-
- Melanoma and MAPK Pathways 17
- Co-authors
- Agop Y. Bedikian (44 shared papers)Carl Plager (22 shared papers)Robert S. Benjamin (19 shared papers)Kevin B. Kim (26 shared papers)Shreyaskumar Patel (12 shared papers)Omar Eton (9 shared papers)Wen-Jen Hwu (20 shared papers)Sigrid Ring (6 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Melanoma Research (13 papers)Cancer (13 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer Investigation (2 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Nicholas E. Papadopoulos
81 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 92
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 600
- Immunology 375
- Ophthalmology 118
- Rheumatology 164
Countries citing papers authored by Nicholas E. Papadopoulos
This map shows the geographic impact of Nicholas E. Papadopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas E. Papadopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas E. Papadopoulos more than expected).
Fields of papers citing papers by Nicholas E. Papadopoulos
This network shows the impact of papers produced by Nicholas E. Papadopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas E. Papadopoulos. The network helps show where Nicholas E. Papadopoulos may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicholas E. Papadopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 257 | |
| 2 | 1998 | 167 | |
| 3 | Osteosarcoma chemotherapy effect: a prognostic factor. | 1987 | 138 |
| 4 | 1989 | 101 | |
| 5 | 2002 | 100 | |
| 6 | 1994 | 89 | |
| 7 | 2002 | 87 | |
| 8 | 1992 | 86 | |
| 9 | 2010 | 65 | |
| 10 | 2004 | 62 | |
| 11 | 2008 | 60 | |
| 12 | 2012 | 60 | |
| 13 | 1995 | 57 | |
| 14 | 2008 | 57 | |
| 15 | 2002 | 54 | |
| 16 | 2005 | 53 | |
| 17 | 2010 | 53 | |
| 18 | 2009 | 53 | |
| 19 | 2012 | 50 | |
| 20 | 2012 | 49 |
About Nicholas E. Papadopoulos
Nicholas E. Papadopoulos is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Ophthalmology and Hematology, having authored 82 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (20 papers), Melanoma and MAPK Pathways (17 papers), Sarcoma Diagnosis and Treatment (13 papers), CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (8 papers), Brain Metastases and Treatment (8 papers), Ocular Oncology and Treatments (8 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (600 citations), Immunology (375 citations), Ophthalmology (118 citations) and Rheumatology (164 citations). Nicholas E. Papadopoulos has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Agop Y. Bedikian, Carl Plager, Robert S. Benjamin, Kevin B. Kim, Shreyaskumar Patel, Omar Eton, Wen-Jen Hwu, Sigrid Ring, Patrick Hwu and Antônio C. Buzaid. Their work appears in journals such as Journal of Clinical Oncology, Melanoma Research, Cancer, Cancer Chemotherapy and Pharmacology and Cancer Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.